Immune-mediated neuropathies.
OBJECTIVE
The immune-mediated neuropathies are an important group of treatable neuropathies that often lead to severe neurologic disability. This review guides clinicians in the recognition and treatment of these disorders.


RESULTS
Advances include new insights in classification and new treatment paradigms in many of these disorders.


CONCLUSIONS
Proper diagnosis and treatment require recognition of the characteristic clinical and laboratory findings and the use of appropriate electrophysiologic or pathologic examination. With proper treatment, partial or complete remission is possible, even in patients who are severely affected.
Stanford University, Department of Neurology, 300 Pasteur Drive, Room A342, Stanford, CA 94305, USA. ytso@stanford.edu
Yuen T
YT
So
D020274:Autoimmune Diseases of the Nervous System; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011115:Polyneuropathies